Cite
HARVARD Citation
Bartsch, R. et al. (n.d.). Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR). Breast. pp. S18-. [Online].